Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.000
-0.170 (-5.36%)
Jun 2, 2026, 5:30 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 112.53 million as of June 2, 2026. Its market cap has decreased by -13.67% in one year.
Market Cap
112.53M
Enterprise Value
37.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 112.53M, a decrease of -73.59%. That is a compound annual growth rate of -10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 118.91M | -6.07% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.76B |
| Idorsia | 1.14B |
| Basilea Pharmaceutica AG | 645.82M |
| Newron Pharmaceuticals | 272.60M |
| Santhera Pharmaceuticals Holding AG | 227.35M |
| BioVersys AG | 157.90M |
| Xlife Sciences AG | 132.65M |
| MindMaze Therapeutics Holding | 57.00M |